Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Tailored ISO 5 RABs Unit To Protect AST's Patented Filling Machine 6/19/2024

    Uncover how AST's satisfaction with Germfree's solution led to the acquisition of two additional units, showcasing the project's success and Germfree's expertise in tailored cleanroom solutions.

  2. AAV Vectors In Gene Therapy Clinical Trials 4/16/2025

    AAV-based gene therapies show promise but face immune challenges. ELISpot assays help evaluate T cell responses, enhancing clinical trial design and improving therapeutic success.

  3. The Business Case For EHR eSource In Clinical Trials 4/12/2024

    Examine how manual data collection challenges prompted the adoption of an eSource solution that streamlined data entry, saving time and costs, reducing errors, and accelerating a multicenter phase 2 trial.

  4. Optimizing Early-Stage Oncology 1/14/2025

    A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.

  5. Get Full Control Of Your T Cell Isolation 3/25/2024

    This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.

  6. Optimizing siRNA Therapeutics: Addressing Manufacturing Complexities 3/21/2025

    Discover key strategies to optimize siRNA therapeutics by addressing critical nonclinical and manufacturing challenges for a smoother path to commercialization.

  7. Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection 7/25/2024

    Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.

  8. Remote Patient Monitoring Using Mobile Health Technology 3/28/2025

    This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.

  9. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

    Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

  10. Unlocking Recruitment Potential In Trial-Naïve Sites 4/17/2025

    Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.